These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 26490711)
21. Energetics, conformation, and recognition of DNA duplexes containing a major adduct of an anticancer azolato-bridged dinuclear Pt(II) complex. Mlcouskova J; Malina J; Novohradsky V; Kasparkova J; Komeda S; Brabec V Biochim Biophys Acta; 2012 Oct; 1820(10):1502-11. PubMed ID: 22683702 [TBL] [Abstract][Full Text] [Related]
22. A molecular view of cisplatin's mode of action: interplay with DNA bases and acquired resistance. Marques MP; Gianolio D; Cibin G; Tomkinson J; Parker SF; Valero R; Pedro Lopes R; Batista de Carvalho LA Phys Chem Chem Phys; 2015 Feb; 17(7):5155-71. PubMed ID: 25601325 [TBL] [Abstract][Full Text] [Related]
23. The repair capacity of lung cancer cell lines A549 and H1299 depends on HMGB1 expression level and the p53 status. Yusein-Myashkova S; Stoykov I; Gospodinov A; Ugrinova I; Pasheva E J Biochem; 2016 Jul; 160(1):37-47. PubMed ID: 26896489 [TBL] [Abstract][Full Text] [Related]
24. Interaction between the anticancer drug Cisplatin and the copper chaperone Atox1 in human melanoma cells. Palm-Espling ME; Lundin C; Björn E; Naredi P; Wittung-Stafshede P Protein Pept Lett; 2014; 21(1):63-8. PubMed ID: 23988033 [TBL] [Abstract][Full Text] [Related]
25. Involvement of high mobility group B proteins in cisplatin-induced cytotoxicity in squamous cell carcinoma of skin. Sharma A; Ramanjaneyulu A; Ray R; Rajeswari MR DNA Cell Biol; 2009 Jul; 28(7):311-8. PubMed ID: 19435426 [TBL] [Abstract][Full Text] [Related]
26. Interaction of cisplatin and analogue Pt(en)Cl2 with the copper metallo-chaperone Atox1. Sze CM; Shi Z; Khairallah GN; Feketeová L; O'Hair RA; Xiao Z; Donnelly PS; Wedd AG Metallomics; 2013 Aug; 5(8):946-54. PubMed ID: 23778981 [TBL] [Abstract][Full Text] [Related]
27. A platinum complex that binds non-covalently to DNA and induces cell death via a different mechanism than cisplatin. Suntharalingam K; Mendoza O; Duarte AA; Mann DJ; Vilar R Metallomics; 2013 May; 5(5):514-23. PubMed ID: 23487034 [TBL] [Abstract][Full Text] [Related]
28. In vitro biochemical and pharmacological evaluation of a novel cytotoxic dinuclear platinum(II) complex with 3-amino-5-methyl-5-phenylhydantoin. Momekov GTs; Ugrinova I; Pasheva EA; Bakalova AG; Varbanov HP; Ferdinandov DV; Ivanov DS; Konstantinov SM Ann N Y Acad Sci; 2009 Aug; 1171():649-58. PubMed ID: 19723116 [TBL] [Abstract][Full Text] [Related]
29. Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin. Takahara PM; Rosenzweig AC; Frederick CA; Lippard SJ Nature; 1995 Oct; 377(6550):649-52. PubMed ID: 7566180 [TBL] [Abstract][Full Text] [Related]
30. Computational insight into the interaction of oxaliplatin with insulin. Sciortino G; Sánchez-Aparicio JE; Rodríguez-Guerra Pedregal J; Garribba E; Maréchal JD Metallomics; 2019 Apr; 11(4):765-773. PubMed ID: 30724953 [TBL] [Abstract][Full Text] [Related]
32. Platinum(IV)-nitroxyl complexes as possible candidates to circumvent cisplatin resistance in RT112 bladder cancer cells. Cetraz M; Sen V; Schoch S; Streule K; Golubev V; Hartwig A; Köberle B Arch Toxicol; 2017 Feb; 91(2):785-797. PubMed ID: 27307157 [TBL] [Abstract][Full Text] [Related]
33. An omics perspective to the molecular mechanisms of anticancer metallo-drugs in the computational microscope era. Spinello A; Magistrato A Expert Opin Drug Discov; 2017 Aug; 12(8):813-825. PubMed ID: 28604114 [TBL] [Abstract][Full Text] [Related]
34. NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin. Gelasco A; Lippard SJ Biochemistry; 1998 Jun; 37(26):9230-9. PubMed ID: 9649303 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive identification of the binding sites of cisplatin in hen egg white lysozyme. Zhang N; Du Y; Cui M; Liu Z; Liu S Anal Bioanal Chem; 2014 Jun; 406(15):3537-49. PubMed ID: 24748452 [TBL] [Abstract][Full Text] [Related]
36. Molecular Recognition of Platinated DNA from Chromosomal HMGB1. Nguyen TH; Rossetti G; Arnesano F; Ippoliti E; Natile G; Carloni P J Chem Theory Comput; 2014 Aug; 10(8):3578-84. PubMed ID: 26588321 [TBL] [Abstract][Full Text] [Related]
37. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy. Gentile F; Tuszynski JA; Barakat KH J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044 [TBL] [Abstract][Full Text] [Related]
38. The inhibitory effect of HMGB-1 protein on the repair of cisplatin-damaged DNA is accomplished through the acidic domain. Mitkova E; Ugrinova I; Pashev IG; Pasheva EA Biochemistry; 2005 Apr; 44(15):5893-8. PubMed ID: 15823048 [TBL] [Abstract][Full Text] [Related]
39. Internalization of Ineffective Platinum Complex in Nanocapsules Renders It Cytotoxic. Vrana O; Novohradsky V; Medrikova Z; Burdikova J; Stuchlikova O; Kasparkova J; Brabec V Chemistry; 2016 Feb; 22(8):2728-35. PubMed ID: 26789279 [TBL] [Abstract][Full Text] [Related]
40. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins. Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]